Efficient recovery of recombinant human erythropoietin from milk of transgenic pigs by two-step pretreatment

被引:1
作者
Lee, Eun Gyo [2 ]
Leez, Seung Hui [1 ]
Park, Kyoung Mi [1 ]
Baek, Jung Eun [2 ]
Park, Jin-Ki [3 ]
Chang, Won-Kyong [3 ]
Jung, Joon-Ki [2 ]
Chung, Bong Hyun [1 ]
机构
[1] KRIBB, BioNanotechnol Res Ctr, Taejon 305806, South Korea
[2] KRIBB, Div Biotechnol R&BD, Biomed Proc Dev Dept, Taejon 305806, South Korea
[3] Natl Livestock Res Inst, Anim Biotechnol Div, Suwon 441706, South Korea
关键词
erythropoietin; transgenic pig; recovery; divalent metal; precipitation;
D O I
10.1007/s12257-007-0158-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The selective removal of impurity proteins and colloidal particles from milk prior to chromatographic purification processes presents a crucial issue in the production of therapeutic proteins from transgenic animals with high recovery yield and purity. We have developed an efficient two-step precipitation method for the recovery of the recombinant human erythropoietin (rhEPO) of interest from transgenic sow milk. Here, rhEPO was partially purified from transgenic sow milk via a two-step precipitation method consisting of ammonium sulfate and divalent metal precipitations, with a yield of approximately 82.1% and a purification fold of 10.4 at a copper concentration of 30 mM. Copper proved to be the strongest flocculating agent among the divalent ions tested for the aggregation of milk proteins under 35%, with ammonium sulfate, zinc, nickel, and calcium demonstrating increasing flocculating capability in the given order. Copper and zinc proved to be appropriate divalent metals for the recovery of rhEPO at high yield and purity, and the optimal concentration ranges of copper and zinc were 20 similar to 40 and 40-80 mM, respectively. (C) KSBB.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 21 条
  • [1] Bell S.J.D., 2002, US Patent, Patent No. [6355271B1, 6355271]
  • [2] Enhancement of erythropoietin production in recombinant Chinese hamster ovary cells by sodium lactate addition
    Choi, Yeon Sook
    Lee, Doo Young
    Kim, Ick Young
    Kim, Hong Jin
    Park, Hong Woo
    Choe, Tae Boo
    Kim, Ik-Hwan
    [J]. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2007, 12 (01) : 60 - 72
  • [3] DAS RC, 2001, BIOBUSINESS, V19, P60
  • [4] Zn2+-selective purification of recombinant proteins from the milk of transgenic animals
    Degener, A
    Belew, M
    Velander, WH
    [J]. JOURNAL OF CHROMATOGRAPHY A, 1998, 799 (1-2) : 125 - 137
  • [5] GENETIC-TRANSFORMATION OF MOUSE EMBRYOS BY MICRO-INJECTION OF PURIFIED DNA
    GORDON, JW
    SCANGOS, GA
    PLOTKIN, DJ
    BARBOSA, JA
    RUDDLE, FH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (12): : 7380 - 7384
  • [6] HUGHES HC, 1986, LAB ANIM SCI, V36, P348
  • [7] High-yield production of functional human lactoferrin in transgenic cell cultures of Siberian ginseng (Acanthopanax senticosus)
    Jo, Seung-Hyun
    Kwon, Suk-Yoon
    Park, Doo-Sang
    Yang, Kyoung-Sil
    Kim, Jae-Whune
    Lee, Ki-Teak
    Kwak, Sang-Soo
    Lee, Haeng-Soon
    [J]. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2006, 11 (05) : 442 - 448
  • [8] Engineering blood cells and proteins as blood substitutes: A short review
    Kim, Hae Won
    [J]. BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2007, 12 (01) : 43 - 47
  • [9] EPO's alter ego: Erythropoietin has multiple actions
    Lappin, TR
    Maxwell, AP
    Johnston, PG
    [J]. STEM CELLS, 2002, 20 (06) : 485 - 492
  • [10] LEE VW, 2003, Patent No. 6525176